Evidence map›Paper›PMID 34260931›Full record

ArticleCell reports2021

Human oncoprotein 5MP suppresses general and repeat-associated non-AUG translation via eIF3 by a common mechanism.

Chingakham Ranjit Singh, M Rebecca Glineburg, Chelsea Moore, Naoki Tani, Rahul Jaiswal, Ye Zou, Eric Aube, Sarah Gillaspie, Mackenzie Thornton, Ariana Cecil and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Male germ cell-specific deletion ofZoological research · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Structural basis for non-AUG translation regulation by 5MPs.bioRxiv : the preprint server for biology · 2025
    Article
  11. The multifaceted roles of ribosomal P complex in cancer.World journal of surgical oncology · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Decoding Nucleotide Repeat Expansion Diseases: Novel Insights fromInternational journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Chingakham Ranjit SinghMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
M Rebecca GlineburgDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Chelsea MooreMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Naoki TaniInstitute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto 860-0811, Japan.
Rahul JaiswalDepartment of Physiology and Biophysics, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
Ye ZouDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506, USA.
Eric AubeMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Sarah GillaspieMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Mackenzie ThorntonMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Ariana CecilMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Madelyn HilgersMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Azuma TakasuMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Izumi AsanoMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Masayo AsanoMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
Carlos R EscalanteDepartment of Physiology and Biophysics, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA.
Akira NakamuraInstitute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto 860-0811, Japan.
Peter K ToddDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; Ann Arbor VA Medical Center, Ann Arbor, MI 48105, USA.
Katsura AsanoMolecular Cellular and Developmental Biology Program, Division of Biology, Kansas State University, Manhattan, KS 66506, USA; Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8530, Japan; Hiroshima Research Center for Healthy Aging, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8530, Japan. Electronic address: kasano@ksu.edu.
Kansas State University · USKumamoto University · JPUniversity of Michigan–Ann Arbor · USVirginia Commonwealth University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI John A Stanford · 2012 to 2026
$63.0M
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disordersP50HD104463 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, TODD, PETER K · 2020 to 2024
$9.0M
Hexanucleotide repeat translation in ALS and Frontotemporal DementiaR01NS099280 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Peter K Todd · 2016 to 2026
$4.9M
Structural and Mechanistic Insights into AAV Rep Mediated Site-Specific Integration and PackagingR01GM124204 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI Carlos R Escalante · 2017 to 2026
$4.2M
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity SupplementR01NS086810 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2014 to 2024
$4.1M
Studies on start codon selection by eukaryotic ribosomesR01GM064781 · NIGMS · KANSAS STATE UNIVERSITY · PI ASANO, KATSURA · 2002 to 2010
$2.4M
Mechanism of stringent translation initiation: a probe for its biological relevanceR01GM147542 · NIGMS · KANSAS STATE UNIVERSITY · PI KATSURA ASANO · 2023 to 2026
$1.2M
The role of translational control in metabolic stress responseR15GM124671 · NIGMS · KANSAS STATE UNIVERSITY · PI ASANO, KATSURA · 2017 to 2020
$899k
Bypassing cellular stress pathways in frontotemporal dementia and ALSI01BX004842 · VA · VETERANS HEALTH ADMINISTRATION · PI TODD, PETER K · 2020 to 2023
–
BLRD VA I01 BX004842NICHD NIH HHS P50 HD104463NIGMS NIH HHS P20 GM103418NIGMS NIH HHS R01 GM064781NIGMS NIH HHS R01 GM124204NIGMS NIH HHS R01 GM147542NIGMS NIH HHS R15 GM124671NINDS NIH HHS R01 NS086810NINDS NIH HHS R01 NS099280
6 · The paper itself

Abstract

eIF5-mimic protein (5MP) is a translational regulatory protein that binds the small ribosomal subunit and modulates its activity. 5MP is proposed to reprogram non-AUG translation rates for oncogenes in cancer, but its role in controlling non-AUG initiated synthesis of deleterious repeat-peptide products, such as FMRpolyG observed in fragile-X-associated tremor ataxia syndrome (FXTAS), is unknown. Here, we show that 5MP can suppress both general and repeat-associated non-AUG (RAN) translation by a common mechanism in a manner dependent on its interaction with eIF3. Essentially, 5MP displaces eIF5 through the eIF3c subunit within the preinitiation complex (PIC), thereby increasing the accuracy of initiation. In Drosophila, 5MP/Kra represses neuronal toxicity and enhances the lifespan in an FXTAS disease model. These results implicate 5MP in protecting cells from unwanted byproducts of non-AUG translation in neurodegeneration.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntigens, DifferentiationCodon, InitiatorDNA-Binding ProteinsDrosophilaDrosophila ProteinsEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-3HEK293 CellsHumansMaleModels, BiologicalModels, MolecularMutationPeptide Chain Initiation, TranslationalAdaptor Proteins, Signal TransducingAntigens, DifferentiationBZW2 protein, humanCodon, InitiatorDNA-Binding ProteinsDrosophila ProteinsEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-3Myd88 protein, DrosophilaReceptors, ImmunologiccancereIF5-mimic proteinFXTASnon-AUG start codonRAN translationribosometranslation initiation

Identifiers

PMID34260931
PMCPMC8363759
OpenAlexW3181933573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.